Literature DB >> 24984691

Practical considerations for using functional uniform prior distributions for dose-response estimation in clinical trials.

Björn Bornkamp1.   

Abstract

Estimating nonlinear dose-response relationships in the context of pharmaceutical clinical trials is often a challenging problem. The data in these trials are typically variable and sparse, making this a hard inference problem, despite sometimes seemingly large sample sizes. Maximum likelihood estimates often fail to exist in these situations, while for Bayesian methods, prior selection becomes a delicate issue when no carefully elicited prior is available, as the posterior distribution will often be sensitive to the priors chosen. This article provides guidance on the usage of functional uniform prior distributions in these situations. The essential idea of functional uniform priors is to employ a distribution that weights the functional shapes of the nonlinear regression function equally. By doing so one obtains a distribution that exhaustively and uniformly covers the underlying potential shapes of the nonlinear function. On the parameter scale these priors will often result in quite nonuniform prior distributions. This paper gives hints on how to implement these priors in practice and illustrates them in realistic trial examples in the context of Phase II dose-response trials as well as Phase I first-in-human studies.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Bayesian statistics; Dose-finding; Emax model; Functional uniform prior; Jeffreys prior

Mesh:

Year:  2014        PMID: 24984691     DOI: 10.1002/bimj.201300138

Source DB:  PubMed          Journal:  Biom J        ISSN: 0323-3847            Impact factor:   2.207


  2 in total

1.  Quantal Risk Assessment Database: A Database for Exploring Patterns in Quantal Dose-Response Data in Risk Assessment and its Application to Develop Priors for Bayesian Dose-Response Analysis.

Authors:  Matthew W Wheeler; Walter W Piegorsch; Albert John Bailer
Journal:  Risk Anal       Date:  2018-10-25       Impact factor: 4.000

2.  How to design a dose-finding study using the continual reassessment method.

Authors:  Graham M Wheeler; Adrian P Mander; Alun Bedding; Kristian Brock; Victoria Cornelius; Andrew P Grieve; Thomas Jaki; Sharon B Love; Lang'o Odondi; Christopher J Weir; Christina Yap; Simon J Bond
Journal:  BMC Med Res Methodol       Date:  2019-01-18       Impact factor: 4.615

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.